1 results match your criteria: "Baylor Medical Center Dallas[Affiliation]"
Article Synopsis
- This trial aimed to compare the effectiveness and safety of two insulin analogues, detemir and glargine, for patients with type 2 diabetes already using oral medications or insulin.
- It was a 52-week, multinational, open-label trial involving patients who had been diagnosed with type 2 diabetes for over a year and were randomized to receive either insulin detemir (once or twice daily) or glargine (once daily) as part of a biological-bolus regimen.
- Key measures included monitoring changes in glycosylated hemoglobin (HbA1c), fasting plasma glucose, and safety indicators like the incidence of hypoglycemia over the study period, with a total of 319 participants involved.